Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroups. - Liu E; Jaouadi O; Sharma R; Becker N; Johnson TS; Sudha P; Chopra VS; Zafar F; Hamidi H; Pawlyn C; Suvannasankha A; Abonour R; et al. (Genome medicine, 2025)